Squarepoint
CRVO icon

Squarepoint’s CervoMed CRVO Stock Holding History

Squarepoint’s Portfolio CRVO Stock Details CRVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-11,557
Closed -$72.6K – 4451
2025
Q2 		$72.6K Buy
+11,557
New +$98.5K ﹤0.01% 4247
2021
Q1 		– Sell
-240
Closed -$14K – 3193
2020
Q4 		$14K Sell
240
-82
-25% -$4.8K ﹤0.01% 2844
2020
Q3 		$20K Sell
322
-743
-70% -$56.5K ﹤0.01% 2418
2020
Q2 		$78K Buy
+1,065
New +$64.8K ﹤0.01% 2053

Other funds holding CRVO

AIC
AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
CFG
Citizens Financial Group Providence, Rhode Island $7.19B AUM 23.93% 1-Year Est. Return
PWM
Perigon Wealth Management San Francisco, California $5.51B AUM 24.51% 1-Year Est. Return
Cetera Investment Advisers
Cetera Investment Advisers Schaumburg, Illinois $94B AUM 20.14% 1-Year Est. Return

Squarepoint's CRVO Position: Q3 2025 in Review

Squarepoint sold out of CervoMed (CRVO) in Q3 2025, closing a stake of 11,557 shares — an estimated $72.6K sold.

Squarepoint first reported a position in CRVO in Q2 2020 and held it in 4 quarters. The position peaked at $78K in Q2 2020. 45 funds tracked by Wall St. Rank hold CRVO as of Q3 2025.

  • Squarepoint reported no remaining CervoMed position as of Q3 2025 after selling out during the quarter.
  • Squarepoint sold 11,557 CervoMed shares in Q3 2025, an estimated $72.6K.
  • Squarepoint first reported a position in CervoMed in Q2 2020 and held it in 4 quarters.
  • Squarepoint's CervoMed position peaked at $78K in Q2 2020.
  • 45 funds tracked by Wall St. Rank held CervoMed as of Q3 2025.

Based on Squarepoint's 13F filing for Q3 2025, filed 14 Nov 2025.